Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding CUPID share price chartink, Cupid share price tradingview, Cupid share price screener, Cupid share price live, Cupid share price NSE, Cupid share price target 2030, and much more. Furthermore, this page provides details on Cupid‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Cupid Company Information
| Number of employees | 217 (2025) |
| Founded |
1993 |
| Headquarters | India |
| Subsidiary | Cupid Medical & Research Centre Pvt. Ltd |
Cupid Share Price Target Overview
- Current Price – 125.88
- Open – 132.01
- High – 132.49
- Low – 119.00
- Mkt cap – 16.93KCr
- P/E ratio – 204.40
- 52-wk high – 132.49
- 52-wk low – 15.90
- Dividend – N/A
- Qtrly div amt – N/A
Cupid Share Price Chart
Cupid Share Price Target Tomorrow
| Cupid Share Price Target Years | Cupid Share Price Target |
| 2026 | ₹140 |
| 2027 | ₹250 |
| 2028 | ₹360 |
| 2029 | ₹470 |
| 2030 | ₹580 |
Cupid Share Price Target 2026
The target for Cupid’s share price in 2026 is projected to range between ₹130 and ₹140. As of the start of May 2026, Cupid’s share price stood at ₹125.88. Compared to the previous year, Cupid’s share price has witnessed an increase this year.
Cupid Share Price Target 2027
The target for Cupid’s share price in 2027 is projected to range between ₹240 and ₹250. On 6 May 2026, Cupid Share price NSE is 125.88 INR. Compared to last year, no significant difference has been observed in the share price of Cupid. The share price has increased by approximately 100-110 rupees.
Cupid Share Price Target 2030
The target for Cupid’s share price in 2030 is projected to range between ₹570 and ₹580. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Risks and Challenges Of Cupid Share Price
Here are 8 key factors affecting the growth of Cupid share price:
1. Overvaluation Risk
- The stock has traded at very high P/E (around 170x), much above industry levels.
- If growth slows even slightly, valuation can correct sharply.
2. High Volatility (Sharp Ups & Downs)
- The stock has already seen big rallies and sudden crashes (30–36% fall in days).
- Small-cap + momentum = high risk for retail investors.
3. Profit Booking After Rally
- After a massive run-up (500%+ returns), investors tend to book profits.
- This creates heavy selling pressure and short-term downside.
4. Regulatory & Compliance Issues
- SEBI warning for disclosure lapses raises governance concerns.
- Even minor compliance issues can hurt investor trust.
5. Surveillance Measures (ASM Impact)
- Stock placed under Additional Surveillance Measures (ASM).
- Leads to:
- Lower liquidity
- Higher margin requirements
- Increased price swings
6. Dependence on Limited Business Segments
- Business is concentrated in contraceptives and related exports.
- Any demand slowdown, tender delay, or regulatory change can hit revenue.
7. Capital Allocation Concerns
- Investments outside core business (like other companies) can worry investors.
- Market may see it as risky use of funds.
8. Market Sentiment & Momentum Dependency
- Stock movement is heavily influenced by sentiment and traders.
- When sentiment changes, price can fall faster than fundamentals.
Read Also:- SRF Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Key Factors Affecting Growth Cupid Share Price
Here are 8 key factors affecting the growth of Cupid share price:
1. Export Demand Growth
- Cupid earns a large portion of revenue from exports (especially Africa & global health programs).
- Higher international demand = strong revenue growth.
2. Government & Institutional Orders
- Orders from organizations like UN agencies and government tenders play a big role.
- Large bulk orders can quickly boost earnings and share price.
3. Product Portfolio Expansion
- Growth depends on adding new products beyond male & female condoms.
- Entry into new healthcare or personal wellness categories can drive future growth.
4. Capacity Expansion
- Increasing manufacturing capacity helps meet rising demand.
- Higher production = higher sales potential = positive impact on stock.
5. Global Health Awareness Trends
- Rising awareness about safe sex and disease prevention globally supports long-term demand.
- This creates a stable growth base for the company.
6. Profit Margins & Cost Control
- Better margins (due to efficient production or lower raw material costs) directly improve profits.
- Strong profitability usually pushes share price upward.
7. New Market Entry
- Expansion into new countries or untapped regions can unlock additional revenue streams.
- Geographic diversification reduces dependency on a few markets.
8. Investor Sentiment & Momentum
- The stock has shown strong momentum in the past.
- Positive news, earnings growth, or hype can quickly attract investors and push the price higher.
Cupid Shareholding Pattern
| Promoter | 46% |
| FII | 1.0% |
| DII | 0.2% |
| Public | 52.8% |
Income Statement Of Cupid
|
All values in INR
|
Mar 2025
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
|---|---|---|---|---|
|
Revenue
|
564.82M
|
598.05M
|
844.47M
|
934.95M
|
|
Cost of goods sold
|
176.80M
|
240.93M
|
342.41M
|
351.44M
|
|
Cost of revenue
|
176.80M
|
240.93M
|
342.41M
|
351.44M
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
98.28M
|
71.10M
|
78.79M
|
80.18M
|
|
Operating expense
|
264.31M
|
204.80M
|
230.97M
|
253.53M
|
|
Total operating expenses
|
441.11M
|
445.73M
|
573.39M
|
604.97M
|
|
Operating income
|
123.71M
|
152.32M
|
271.08M
|
329.99M
|
|
Other non operating income
|
-147.50M
|
49.42M
|
57.83M
|
34.15M
|
|
EBT including unusual items
|
160.40M
|
195.51M
|
321.89M
|
432.74M
|
|
EBT excluding unusual items
|
127.63M
|
195.51M
|
321.89M
|
358.02M
|
|
Income tax expense
|
44.87M
|
45.44M
|
80.59M
|
104.40M
|
|
Effective tax rate
|
27.97%
|
23.24%
|
25.04%
|
24.12%
|
|
Other operating expenses
|
153.46M
|
121.27M
|
139.14M
|
160.32M
|
|
Net income
|
115.54M
|
150.07M
|
241.30M
|
328.34M
|
|
Net profit margin
|
20.46%
|
25.09%
|
28.57%
|
35.12%
|
|
Earnings per share
|
–
|
–
|
–
|
–
|
|
Interest and investment income
|
158.04M
|
–
|
–
|
–
|
|
Interest expense
|
-6.62M
|
-6.22M
|
-7.02M
|
-6.11M
|
|
Net interest expenses
|
151.42M
|
-6.22M
|
-7.02M
|
-6.11M
|
|
Depreciation and amortization charges
|
12.57M
|
12.43M
|
13.05M
|
13.02M
|
|
EBITDA
|
131.90M
|
163.50M
|
283.82M
|
338.18M
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.